Home › Funds › KVP Capital Advisors, LP › AXSM
KVP Capital Advisors, LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
KVP Capital Advisors, LP reported holding 12,000 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$2.9M, representing 2.16% of its reported portfolio and ranking #18 among its reported holdings. KVP Capital Advisors, LP has disclosed AXSM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's AXSM position evolved
KVP Capital Advisors, LP first disclosed a stake in AXSM in Q4 2025 at 36,200 shares (US$6.6M). Across 3 filings, KVP Capital Advisors, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 12,000 shares valued at US$2.9M — a reduction of -24,200 shares quarter over quarter.. Notable position changes include a 67% trim in Q2 2026 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 36.20K | $6.61M | New |
| Q1 2026 | 36.20K | $6.12M | Hold |
| Q2 2026 | 12.00K | $2.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 648.76K sh · $158.80M · Q2 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held AXSM?
KVP Capital Advisors, LP has disclosed AXSM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is KVP Capital Advisors, LP's current position in AXSM?
As of Q2 2026, KVP Capital Advisors, LP holds 12.00K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $2.94M, representing 2.16% of its reported portfolio and ranking #18.
Has KVP Capital Advisors, LP been buying or selling AXSM?
In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP reduced its position in AXSM.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.